The Immunofluorescence Assay Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Immunofluorescence Assay Market:
https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report
According to The Business Research Company’s Immunofluorescence Assay Global Market Report 2024, The immunofluorescence assay market size has grown strongly in recent years. It will grow from $3.18 billion in 2023 to $3.43 billion in 2024 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increased disease diagnosis, rise in research and development, rise in autoimmune diseases, increased cancer diagnostics, rise in virology research.
The immunofluorescence assay market size is expected to see strong growth in the next few years. It will grow to $4.9 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to increasing personalized medicine, rising infectious disease surveillance, rising autoimmune disorders, rising point-of-care testing, increasing global health preparedness. Major trends in the forecast period include multiplexing assays, automation and robotics, high-content imaging, advanced fluorophores, digital pathology integration.
The increasing prevalence of chronic diseases is significantly driving the growth of the immunofluorescence assay market. The changing lifestyle, dietary habits, and improper weight management are contributing to the rapid growth in chronic conditions and a few prolonged chronic infections are leading to cancerous risk. The growing prevalence of chronic disease is expected to boost demand for immunofluorescence assays as they are widely used in diagnosis and drug development activities. For instance, according to the study published by the Centers for Disease Control and Prevention, approximately 6 in 10 adults in the USA are affected by chronic disease, and it is also accounting for $3.8 trillion in annual healthcare costs. Therefore, the increasing prevalence of chronic diseases is expected to boost demand for immunofluorescence assay during forecast period.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=6778&type=smp
The immunofluorescence assay market covered in this report is segmented –
1) By Type: Direct Immunofluorescence, Indirect Immunofluorescence
2) By Product: Reagents, Instruments, Antibodies, Kits, Consumables and Accessories
3) By Disease: Cancer, Infectious Disease, Cardiovascular Diseases, Autoimmune Diseases, Other Diseases
4) By End User: Academic & Research Institutions, Pharmaceutical & Biotechnology Companies, Contract Research Organizations, Hospitals & Diagnostic Centers
Technological advancement is a key trend gaining popularity in the immunofluorescence assay market. The companies operating in immunofluorescence assay are focusing on developing technologically innovative products to meet specific technical demands for the diagnostic of new viruses such as COVID-19 and strengthen their market position. For instance, in March 2022, LumiraDx, a UK-based developer of point-of-care diagnostics, received emergency approval for LumiraDx SARS-CoV-2 Ag Test, a microfluidic immunofluorescence assay, designed for qualitative nucleocapsid protein antigen detection from nasal swab samples.
The immunofluorescence assay market report table of contents includes:
.
.
.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Overview and Scope Dextrose refers to a basic sugar derived from corn or wheat that…
Overview and Scope Device as a Service refers to a subscription-based service that provides businesses…
Overview and Scope Dermatology OTC medications are non-prescription drugs used to prevent and cure conditions…
Overview and Scope Dental milling machines refer to computer-controlled small cutting devices utilized in dentistry…
Overview and Scope Demand planning solutions refer to the process of software or systems that…
Overview and Scope Refinish paint, also known as refinishing paint, refers to a type of…